28
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Therapeutic trials in 200 patients with HTLV-Iassociated myelopathy/tropical spastic paraparesis

, , , , , , , & show all
Pages 345-355 | Received 13 Jul 1995, Accepted 01 Nov 1995, Published online: 10 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Fabiola Martin, Graham P Taylor & Steven Jacobson. (2014) Inflammatory manifestations of HTLV-1 and their therapeutic options. Expert Review of Clinical Immunology 10:11, pages 1531-1546.
Read now
Kimiyoshi Arimura, Masanori Nakagawa, Shuji Izumo, Koichiro Usuku, Yasuto Itoyama, Jun-ichi Kira & Mitsuhiro Osame. (2007) Safety and efficacy of interferon-α in 167 patients with human T-cell lymphotropic virus type 1–associated myelopathy. Journal of Neurovirology 13:4, pages 364-372.
Read now
Hirohisa Nose, Mineki Saito, Koichiro Usuku, Amir H Sabouri, Toshio Matsuzaki, Ryuji Kubota, Nobutaka Eiraku, Yoshitaka Furukawa, Shuji Izumo, Kimiyoshi Arimura & Mitsuhiro Osame. (2006) Clinical symptoms and the odds of human T-cell lymphotropic virus type 1–associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: Application of best-fit logistic regression equation based on host genotype, age, and provirus load. Journal of Neurovirology 12:3, pages 171-177.
Read now
Norihiro Takenouchi, Yoshihisa Yamano, Koichiro Usuku, Mitsuhiro Osame & Shuji Izumo. (2003) Usefulness of Proviral Load Measurement for Monitoring of Disease Activity in Individual Patients with Human T-Lymphotropic Virus Type I-Associated Myelopathy/Tropical Spastic Paraparesis. Journal of Neurovirology 9:1, pages 29-35.
Read now
Masahiro Nagai & Mitsuhiro Osame. (2002) Pathogenesis and treatment of human T-cell lymphotropic virus Type I-associated myelopathy. Expert Review of Neurotherapeutics 2:6, pages 891-899.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.